About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Combination Therapy: Promising Rationale for Alzheimer’s Disease
Xuekai Zhang1, Jing Shi1, Ting Li1, Mingqing Wei1, Jingnian Ni1, Yongyan Wang2, Jinzhou Tian1
1BUCM Neurology Centre, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China; 2Institute of Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 100700, China.
Corresponding Author:
Dr. Jinzhou Tian
Email: jztian@hotmail.com
Received: 30-MAY-2016 Accepted: 23-AUG-2016 Published Online: 25-SEP-2016
DOI: http://dx.doi.org/10.17659/01.2016.0110
Abstract
Donepezil treatment may associated with slow cognitive decline effects for a limited period of time in Alzheimer’s disease (AD). We report a 78 year old highly educated man of mild to moderate probable AD treated by a combination therapy of donepezil, nicergoline, nimodipine and TCM herbal therapy. His cognitive function and global status improved slowly over 2.5 years, from 21 scores on MMSE at first visit to 28 scores on MMSE at final visit. The diagnosis of AD was made mainly based on his complaint of memory loss, hidden onset, and gradually increased medical history, objective evidence of neuropsychological tests demonstrating cognitive impairment and hippocampal atrophy on MRI. His mild dementia slowly showed improvement to normal cognition over a period of 2.5 years. Further studies are needed to define the role of combination therapy in treating Alzheimer’s disease.
Keywords : Alzheimer Disease, Atrophy, Memory Disorders, Nicergoline, Nimodipine.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share